World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
97
Citations
42717
World Ranking
9146
National Ranking
4718

Brad H. Rovin publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Brad H. Rovin sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 454 publications — 50th percentile

50% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Brad H. Rovin D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Brad H. Rovin sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 97 D-Index — 55th percentile

55% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Brad H. Rovin is affiliated with The Ohio State University in the United States and conducts research primarily within the field of Medicine, with a significant focus on Nephrology. Their work spans multiple specialized subfields including Rheumatology, Immunology, Hematology, and Genetics.

Their research topics concentrate heavily on renal and immune-related diseases. Key research areas include:

  • Renal Diseases and Glomerulopathies
  • Systemic Lupus Erythematosus Research
  • Chronic Kidney Disease and Diabetes
  • Platelet Disorders and Treatments
  • Liver Diseases and Immunity
  • Complement system in diseases
  • Vasculitis and related conditions

Brad H. Rovin has contributed substantially to peer-reviewed literature, with frequent publications in respected journals such as:

  • Kidney International
  • Journal of the American Society of Nephrology
  • Kidney International Reports
  • Nephrology Dialysis Transplantation
  • Annals of the Rheumatic Diseases

Recent significant papers authored or co-authored by Brad H. Rovin include:

  • KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases (2021) in Kidney International
  • Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis (2020) in New England Journal of Medicine
  • Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases (2021) in Kidney International
  • An atlas of healthy and injured cell states and niches in the human kidney (2023) in Nature
  • Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial (2021) in The Lancet

Collaboration is a notable aspect of their scientific activity. Frequent co-authors include:

  • Jonathan Barratt
  • Jai Radhakrishnan
  • Pierre Ronco
  • Jürgen Floege
  • Ana Malvar

The research contributions of Brad H. Rovin explore clinical and translational nephrology topics, with a special emphasis on glomerular diseases and autoimmune conditions affecting the kidney. Their work also intersects with broader immunological and hematological mechanisms relevant to chronic kidney disease and systemic inflammatory disorders.

Best Publications

  • Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The lupus nephritis assessment with rituximab study†

    Brad H. Rovin;Richard Furie;Kevin Latinis;R. John Looney

  • The Influence of CCL3L1 Gene-Containing Segmental Duplications on HIV-1/AIDS Susceptibility

    Enrique Gonzalez;Hemant Kulkarni;Hector Bolivar;Andrea Mangano

  • KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases

    Brad H. Rovin;Sharon G. Adler;Jonathan Barratt;Frank Bridoux

  • Mycophenolate Mofetil versus Cyclophosphamide for Induction Treatment of Lupus Nephritis

    Gerald B. Appel;Gabriel Contreras;Mary Anne Dooley;Ellen M. Ginzler

  • Kidney disease: Improving global outcomes (KDIGO) glomerulonephritis work group. KDIGO clinical practice guideline for glomerulonephritis

    Daniel C. Cattran;John Feehally;H. Terence Cook;Zhi Hong Liu

  • Update on Lupus Nephritis

    Salem Almaani;Alexa Meara;Brad H. Rovin

  • Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis

    Richard Furie;Brad H. Rovin;Frederic Houssiau;Ana Malvar

  • A novel polymorphism in the MCP-1 gene regulatory region that influences MCP-1 expression.

    Brad H. Rovin;Ling Lu;Ramesh Saxena

  • Gene Copy-Number Variation and Associated Polymorphisms of Complement Component C4 in Human Systemic Lupus Erythematosus (SLE): Low Copy Number Is a Risk Factor for and High Copy Number Is a Protective Factor against SLE Susceptibility in European Americans

    Yan Yang;Erwin K. Chung;Yee Ling Wu;Stephanie L. Savelli

  • Activation of Nrf2/ARE pathway protects endothelial cells from oxidant injury and inhibits inflammatory gene expression.

    Xi-Lin Chen;Geraldine Dodd;Suzanne Thomas;Xiaolan Zhang

  • Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases.

    Brad H. Rovin;Sharon G. Adler;Jonathan Barratt;Frank Bridoux

  • Flavopiridol administered using a pharmacologically derived schedule is associated with marked clinical efficacy in refractory, genetically high-risk chronic lymphocytic leukemia.

    John C. Byrd;Thomas S. Lin;James T. Dalton;Di Wu

  • Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy

    Fernando C. Fervenza;Gerald B. Appel;Sean J. Barbour;Brad H. Rovin

  • Lupus nephritis is linked to disease-activity associated expansions and immunity to a gut commensal

    Doua Azzouz;Aidana Omarbekova;Adriana Heguy;Dominik Schwudke

  • HIV-1 infection and AIDS dementia are influenced by a mutant MCP-1 allele linked to increased monocyte infiltration of tissues and MCP-1 levels

    Enrique Gonzalez;Brad H. Rovin;Luisa Sen;Glen Cooke

  • Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial.

    Brad H Rovin;Y K Onno Teng;Ellen M Ginzler;Cristina Arriens

  • Warfarin-related nephropathy occurs in patients with and without chronic kidney disease and is associated with an increased mortality rate

    Sergey V. Brodsky;Tibor Nadasdy;Brad H. Rovin;Anjali A. Satoskar

  • Update on Lupus Nephritis: Core Curriculum 2020.

    Samir V. Parikh;Salem Almaani;Sergey Brodsky;Brad H. Rovin

  • Urine Chemokines as Biomarkers of Human Systemic Lupus Erythematosus Activity

    Brad H. Rovin;Huijuan Song;Dan J. Birmingham;Lee A. Hebert

  • Uric acid and cardiovascular risk.

    Lee A Hebert;Brad Rovin

Frequent Co-Authors

Jürgen Floege
Jürgen Floege RWTH Aachen University
Jon B. Klein
Jon B. Klein University of Louisville
David S. Pisetsky
David S. Pisetsky Duke University
Ellen M. Ginzler
Ellen M. Ginzler SUNY Downstate Medical Center
Kenneth C. Kalunian
Kenneth C. Kalunian University of California, San Diego
Cynthia Aranow
Cynthia Aranow Feinstein Institute for Medical Research
Betty P. Tsao
Betty P. Tsao University of California, Los Angeles
Hans-Joachim Anders
Hans-Joachim Anders Ludwig-Maximilians-Universität München
Michelle Petri
Michelle Petri Johns Hopkins University School of Medicine

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those passionate about healthcare but seeking alternative educational pathways, a variety of online degrees offer flexible options to launch or advance a career in medicine and related fields. These online programs can often be more accessible, allowing you to balance studies with work or family commitments.

Aspiring advanced practice nurses might consider the easiest dnp program online to quickly gain credentials for leadership, clinical, or academic positions. If you're interested in becoming a nurse more rapidly, online lpn programs offer a streamlined route to licensure and practical experience.

Mental health is a growing field, and earning your credentials through online psych np programs can open doors to high-demand roles in psychiatric care. Meanwhile, for those interested in the business and administration side of healthcare, the online master of health administration prepares graduates for leadership opportunities in hospitals, clinics, and health organizations.

Each of these online pathways can pave the way to rewarding careers in healthcare without the need for a traditional, on-campus medical degree.

Best Scientists Citing Brad H. Rovin

Trending Scientists

Recently Published Articles